SEC 13F Intelligence

Duquesne Family Office LLC / MRNA

Duquesne Family Office LLC’s Moderna Inc Position

Does Duquesne Family Office LLC own Moderna Inc (MRNA)? Not currently — the last reported position was 22.2K shares worth $3M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q1 2023
Shares
22.2K
% of Portfolio
+0.15%
Quarters Held
6
position exited

Position History MRNA

Reported value by quarter
Q2 ’21: $52MQ2 ’21Q3 ’21: $33MQ3 ’21Q2 ’22: $30MQ2 ’22Q3 ’22: $3MQ3 ’22Q4 ’22: $4MQ4 ’22Q1 ’23: $3MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202322.2K$3M+0.15%
Q4 202222.2K$4M+0.20%
Q3 202222.2K$3M+0.15%
Q2 2022207.7K$30M+2.15%
Q3 202186.0K$33M+1.07%
Q2 2021222.4K$52M+1.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of MRNA.